COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
出版年份 2022 全文链接
标题
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 18, Issue 4, Pages 191-204
出版商
Springer Science and Business Media LLC
发表日期
2022-02-25
DOI
10.1038/s41584-022-00755-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
- (2022) Pedro M Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2022) Obbina Abani et al. LANCET
- Global research collaboration in a pandemic-challenges and opportunities
- (2021) Philip C. Robinson et al. CURRENT OPINION IN RHEUMATOLOGY
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 epidemiology in rheumatic diseases in Tuscany: a case control study
- (2021) Paolo Francesconi et al. JOINT BONE SPINE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
- (2021) Martin Schäfer et al. ANNALS OF THE RHEUMATIC DISEASES
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis
- (2021) Guiling Xiang et al. Annals of Palliative Medicine
- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data
- (2021) Gabriel Chodick et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- COVID-19 and disparities affecting ethnic minorities
- (2021) Daniel R Morales et al. LANCET
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1
- (2021) Jeffrey R Curtis et al. Arthritis & Rheumatology
- Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals
- (2021) Bryant R. England et al. Arthritis & Rheumatology
- Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
- (2021) Syed Ali Husain et al. Kidney International Reports
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series
- (2021) Caoilfhionn M. Connolly et al. ANNALS OF INTERNAL MEDICINE
- Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
- (2021) Claire Cook et al. ANNALS OF THE RHEUMATIC DISEASES
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
- (2021) Maria Prendecki et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
- (2021) Renaud Felten et al. ANNALS OF THE RHEUMATIC DISEASES
- AB0634 BELIEFS ABOUT URATE LOWERING THERAPY DIFFER BETWEEN GENERAL PRACTITIONERS AND RHEUMATOLOGISTS
- (2021) F. Veenstra et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series
- (2021) Caoilfhionn M Connolly et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic rheumatic disease flares after SARS-CoV-2 vaccination among rheumatology outpatients in New York City
- (2021) Medha Barbhaiya et al. ANNALS OF THE RHEUMATIC DISEASES
- Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
- (2021) Larissa Valor-Méndez et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
- (2021) Mark W Tenforde et al. CLINICAL INFECTIOUS DISEASES
- BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
- (2021) Tal Brosh-Nissimov et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance
- (2021) Bonnie L. Bermas et al. JOURNAL OF RHEUMATOLOGY
- Hospitalisation among vaccine breakthrough COVID-19 infections
- (2021) Prerak V Juthani et al. LANCET INFECTIOUS DISEASES
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants in Patients with Immunosuppression
- (2021) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS‐CoV‐2 Messenger RNA Vaccination
- (2021) Caoilfhionn M. Connolly et al. Arthritis & Rheumatology
- Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination
- (2021) Peter M. Izmirly et al. Arthritis & Rheumatology
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
- (2021) Hector Rincon-Arevalo et al. Science Immunology
- COVID-19 vaccine side effects: The positives about feeling bad
- (2021) Jonathan Sprent et al. Science Immunology
- Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
- (2021) Abi Vijenthira et al. Blood Advances
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2021) Sebastian Eduardo Sattui et al. RMD Open
- The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
- (2021) Renaud Felten et al. Lancet Rheumatology
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
- (2021) Laura Boekel et al. Lancet Rheumatology
- Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
- (2021) Matthias B Moor et al. Lancet Rheumatology
- Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
- (2021) George R Painter et al. Current Opinion in Virology
- Rituximab impairs B‐cell response but not T‐cell response to COVID ‐19 vaccine in auto‐immune diseases
- (2021) Samuel Bitoun et al. Arthritis & Rheumatology
- SARS‐CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta‐Analysis
- (2021) Richard Conway et al. Arthritis & Rheumatology
- B‐cell reconstitution is strongly associated with COVID ‐19 vaccine responsiveness in rheumatic disease patients treated with rituximab
- (2021) Sarah Jinich et al. Arthritis & Rheumatology
- B cell numbers predict humoral and cellular response upon SARS‐CoV ‐2 vaccination among patients treated with rituximab
- (2021) Ana L. Stefanski et al. Arthritis & Rheumatology
- What does endemic COVID-19 mean for the future of rituximab?
- (2021) David F L Liew et al. Lancet Rheumatology
- Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
- (2021) Youn Ho Shin et al. Lancet Rheumatology
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
- (2021) Sebastian E Sattui et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults
- (2020) Supinda Bunyavanich et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 and Racial/Ethnic Disparities
- (2020) Monica Webb Hooper et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
- (2020) Philip C. Robinson et al. Nature Reviews Rheumatology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance
- (2020) Zachary S Wallace et al. RHEUMATOLOGY
- Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings
- (2020) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
- (2020) Robert BM Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Age-dependent effects in the transmission and control of COVID-19 epidemics
- (2020) Nicholas G. Davies et al. NATURE MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice
- (2020) Jean W Liew et al. RHEUMATOLOGY
- Susceptibility to COVID‐19 in patients treated with antimalarials: a population based study in Emilia‐Romagna, Northern Italy
- (2020) Carlo Salvarani et al. Arthritis & Rheumatology
- Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
- (2020) Eric A. Meyerowitz et al. ANNALS OF INTERNAL MEDICINE
- Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
- (2020) Mette Reilev et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
- (2020) Dillon C. Adam et al. NATURE MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
- (2020) Mary Kathryn Bohn et al. PHYSIOLOGY
- The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus
- (2020) Joyce C. Chang et al. ARTHRITIS CARE & RESEARCH
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
- (2020) Stephanie L. Harrison et al. PLOS MEDICINE
- Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
- (2020) Naomi Serling-Boyd et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL MICROBIOLOGY AND INFECTION
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
- (2020) Isabelle Amigues et al. Expert Review of Clinical Immunology
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
- (2020) René Cordtz et al. RHEUMATOLOGY
- COVID‐19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi‐Center Comparative Cohort Study
- (2020) Kristin M. D’Silva et al. Arthritis & Rheumatology
- Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry
- (2020) Milena A. Gianfrancesco et al. Arthritis & Rheumatology
- Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial
- (2019) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Type I Interferon in the Pathogenesis of Lupus
- (2014) M. K. Crow JOURNAL OF IMMUNOLOGY
- Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study
- (2012) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoimmunity as a Predisposition for Infectious Diseases
- (2010) Mohan S. Maddur et al. PLoS Pathogens
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now